PMID: 15383565Sep 24, 2004Paper

Development of CD4+ macrophages from intrathymic T cell progenitors is induced by thymic epithelial cells

The Journal of Immunology : Official Journal of the American Association of Immunologists
Eiji EsashiAtsushi Miyajima

Abstract

It was recently demonstrated that there are CD4(+) macrophages, which exhibit strong phagocytic activity, in the thymus. They are suggested to play an important role for the elimination of apoptotic thymocytes. However, the origin and nature of CD4(+) macrophages in the thymus remain unexplored. In this study, we describe that the most immature intrathymic progenitors (CD25(-)/CD44(+)/FcR(+)) give rise to CD4(+) macrophages by oncostatin M-responsive thymic epithelial cells (ORTEC) in an IL-7-dependent manner. Neither conditioned medium of ORTEC nor a mixture of cytokines induced CD4(+) macrophages, and oncostatin M receptor was not expressed in thymocytes, suggesting that the development of CD4(+) macrophages from the immature thymocytes requires a direct interaction with ORTEC. These results collectively suggest that the development of CD4(+) macrophages from the intrathymic T cell progenitors is induced by thymic epithelial cells.

References

Aug 1, 1994·Immunology Today·P G Ashton-Rickardt, S Tonegawa
Nov 1, 1994·The Journal of Experimental Medicine·J J PeschonB L Davison
Jan 1, 1994·Annual Review of Immunology·E Robey, B J Fowlkes
Mar 1, 1994·European Journal of Immunology·B PéaultI L Weissman
Apr 1, 1996·The Journal of Experimental Medicine·G Süss, K Shortman
Jan 1, 1996·Annual Review of Immunology·G AndersonE J Jenkinson
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·N PlattS Gordon
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·D B KlugE R Richie
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·H R RodewaldC Haller
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C K LeeS S Han
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R E MebiusK Akashi
Jun 7, 2002·Mechanisms of Development·Shinobu TamuraEmiko Senba
Sep 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eiji EsashiAtsushi Miyajima

❮ Previous
Next ❯

Citations

Mar 20, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zipei FengBernard A Fox
Oct 4, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher T DeeAdam F L Hurlstone
Apr 8, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevin MaiseyMónica Imarai
Jan 10, 2018·Frontiers in Pharmacology·Krisztina KöröskényiZsuzsa Szondy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.